Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.5700
+0.0300 (5.56%)
At close: Mar 27, 2026
Nyrada Market Cap
Nyrada has a market cap or net worth of 139.62 million as of March 27, 2026. Its market cap has increased by 532.20% in one year.
Market Cap
139.62M
Enterprise Value
132.50M
Revenue
2.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.57
Market Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 139.62M, an increase of 443.16%. That is a compound annual growth rate of 31.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 139.62M | -48.75% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 234.54M |
| Orthocell | 210.26M |
| Starpharma Holdings | 195.26M |
| Dimerix | 195.13M |
| Recce Pharmaceuticals | 137.36M |
| Actinogen Medical | 129.30M |
| Amplia Therapeutics | 125.70M |
| Paradigm Biopharmaceuticals | 113.45M |